We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Tenax Therapeutics Inc | NASDAQ:TENX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.90 | 3.61 | 3.90 | 2 | 10:12:20 |
Delaware
|
|
001-34600
|
|
26-2593535
|
(State
or other jurisdiction of incorporation)
|
|
(CommissionFile
Number)
|
|
(IRS
EmployerIdentification No.)
|
Exhibit No.
|
|
Description
|
|
Press
Release dated July 28, 2017
|
Date: July 28, 2017
|
Tenax Therapeutics, Inc.
|
|
|
|
|
|
|
|
|
By: /s/
Michael Jebsen
|
|
|
Michael
Jebsen
|
|
|
Interim
Chief Executive Officer and Chief Financial
Officer
|
|
Exhibit No.
|
|
Description
|
|
Press
Release dated July 28, 2017
|
1 Year Tenax Therapeutics Chart |
1 Month Tenax Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions